
Dr Dominic Williams
Senior Lecturer Pharmacology & Therapeutics
- Work email Dom@liverpool.ac.uk
- About
- Research
- Publications
Research
Research Grants
Chemical stress.
WELLCOME TRUST (UK)
August 2004 - September 2004
Development of an in vitro microsomal assay that can determine the rate of consumption of reduced glutathione
WELLCOME TRUST (UK)
July 2011 - August 2011
Mechanistic investigation into novel rodenticides
BASF PLC (UK)
February 2010 - January 2013
University of Liverpool Institutional Discipline Bridging.
MEDICAL RESEARCH COUNCIL
October 2003 - October 2006
Role of inflammation in organ-selective off target adverse drug reactions
MINISTRY OF HIGHER EDUCATION (MALAYSIA)
July 2012 - June 2015
Towards NanoMedicine Interventions for HIV/AIDS
ENGINEERING & PHYSICAL SCIENCES RESEARCH COUNCIL
May 2012 - November 2016
In vivo physiological mechanisms underlying a1-adrenoceptor mediated protection during drug-induced hepatotoxicity in the mouse
BIOTECHNOLOGY & BIOLOGICAL SCIENCE RESEARCH COUNCIL
October 2007 - September 2008
Investigation of Inflammatory Signalling during Drug-induced Hepatotoxicity Background
BRITISH TOXICOLOGY SOCIETY (UK)
October 2007 - September 2010
The chemical and molecular basis of the prevention of drug-induced liver injury by Nrf2.
WELLCOME TRUST (UK)
January 2007 - December 2009
Investigation into drug toxicity using high density array analysis corroborated with Northern Blot, real time PCR and RT-PCR.
WELLCOME TRUST (UK)
July 2001 - September 2001
Hepatocyte protein adduct formation with paracetamol and furosemide.
WELLCOME TRUST (UK)
June 2005 - August 2005
Paracetamol and PARP inhibitors
ASTRAZENECA LIMITED (UK)
November 2010 - February 2012
Research Collaborations
Gallagher / Jarvis
Internal
Alkaptonuria research
Prof ANja Kipar
Internal
CDSS Pathology collaboration
Integrative Toxicology Training Programme
External: Medical Research Council
Research & Development
External: Sorex, BASF
New Opportunities Group
External: AstraZeneca Pharmceuticals
Group
External: AstraZeneca Pharmceuticals
Drug-induced hepatic toxicity
Group
External: Pfizer Ltd
Investigation of reactive and potentially toxic intermediates
Transmitter Group
External: The University of Nottingham
Measurement of serum catecholamines
Group
External: AstraZeneca Pharmceuticals
Bioactivation of drugs
Group
External: Pfizer Ltd
Transcription factor activation as safety assessment